Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Real-World Use of Semaglutide for Weight Management: Dose Titration, Discontinuation Patterns and Weight Changes
Diabetes, obesity & metabolism, 2026
Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability
Diabetes, obesity & metabolism, 2026
Glucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis
Translational psychiatry, 2026
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis
BMJ (Clinical research ed.), 2026;394:e372161
The Neuroendocrine-Appetite-Mental Health Triangle in PMOS: Implications for GLP-1 Receptor Agonist Therapy
Neuroscience and biobehavioral reviews, 2026;:106846
GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
Cell chemical biology, 2026
Effects of tirzepatide therapy on body weight and body composition in adults with overweight and obesity
Frontiers in endocrinology, 2026;17:1834580
Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response?
Journal of the Endocrine Society, 2026;10(8):bvag149
Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications-A Narrative Review
International journal of molecular sciences, 2026;27(14)
Semaglutide Modulates Visceral Adipose Tissue Lipid Metabolism in Type 2 Diabetic Mice: A Lipidomics Study
Frontiers in bioscience (Landmark edition);31(6):49873
Harnessing the Reactivity of Sulfinate Salts With Cystine: An Umpolung Approach to Residue-Specific Peptide Modification
Angewandte Chemie (International ed. in English), 2026;:e5484068
Sirtuin 1 deficiency mediates chronic kidney disease-induced inflammaging cardiovascular calcification
Molecular biomedicine, 2026;7(1)
Effects of Tirzepatide in Obesity-Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Trial
JACC. Heart failure, 2026;:103218
Role of GLP-1 receptor agonists in the prevention and treatment of obesity-related cancer
Internal and emergency medicine, 2026
Computational Trial of Prophylactic Biostimulator Interventions to Mitigate Facial Sagging Associated With GLP-1 Receptor Agonist Induced Weight Loss
Aesthetic plastic surgery, 2026
GLP-1 medications: use and interest in a representative survey of Finns
International journal of obesity (2005), 2026
Brain Neuromodulation via Endoscopic Gastric Implant Improves Glycemic Control in Insulin-Dependent Type-2 Diabetes: First-in-Human Feasibility and Autonomic Response Study
Journal of laparoendoscopic & advanced surgical techniques. Part A, 2026;:10926429261468981
Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer’s disease
Cell reports. Medicine, 2026;:102906
Changes in patient-reported outcomes and objective assessments based on baseline symptom severity in SURMOUNT-OSA: Post-hoc analyses
Sleep, 2026
Coronary artery disease -related outcomes associated with semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis
Nutrition, metabolism, and cardiovascular diseases : NMCD, 2026;:104859